- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-994X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mapping genetic interactions in cancer: a road to rational combination therapies ; volume:11 ; number:1 ; day:22 ; month:10 ; year:2019 ; pages:1-12 ; date:12.2019
Genome medicine ; 11, Heft 1 (22.10.2019), 1-12, 12.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13073-019-0680-4
- URN
-
urn:nbn:de:101:1-2020021602483760956743
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tutuncuoglu, Beril
- Krogan, Nevan J.
- SpringerLink (Online service)
Other Objects (12)
Nanomedicine formulations for combination therapies
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
Surgery in the combination therapies era
Combination therapies utilizing neoepitope-targeted vaccines
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
The future of combination therapies in advanced melanoma
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer Cells
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Nanomedicine formulations for combination therapies
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
Surgery in the combination therapies era
Combination therapies utilizing neoepitope-targeted vaccines
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
The future of combination therapies in advanced melanoma
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer Cells
Alzheimer’s Disease: Combination Therapies and Clinical Trials for Combination Therapy Development
Nanomedicine formulations for combination therapies
Tipping the balance: toward rational combination therapies to overcome venetoclax resistance in mantle cell lymphoma
Modeling chemotherapy-induced stress to identify rational combination therapies in the DNA damage response pathway
Surgery in the combination therapies era
Combination therapies utilizing neoepitope-targeted vaccines
Novel combination therapies for BRAF-mutant melanoma
Combination therapies for cancer: challenges and opportunities
Combination therapies enhance immunoregulatory properties of MIAMI cells
CAR-T cell combination therapies in hematologic malignancies
The future of combination therapies in advanced melanoma
Rational Design of HER2-Targeted Combination Therapies to Reverse Drug Resistance in Fibroblast-Protected HER2+ Breast Cancer Cells